Literature DB >> 3881767

Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate.

M Malkovský, P B Medawar, D R Thatcher, J Toy, R Hunt, L S Rayfield, C Doré.   

Abstract

The susceptibility of newborn mice to the inception of tolerance after exposure to antigen is associated with their deficiency in the production of endogenous interleukin 2 (IL-2). As further evidence of the complicity of IL-2 in the inception and maintenance of tolerance, it is shown here that a solid and long-lasting state of tolerance induced by the intravenous injection into newborn CBA mice of lymphoid cells from (CBA X C57BL/10ScSn)F1 hybrids can be brought to an end by the administration of exogenous IL-2 or by supplementing an otherwise normal diet with vitamin A acetate, the effect of which is to increase the proportion of the moiety of the T-cell population that produces IL-2. These results indicate that certain nonspecific stimuli can influence whether immunological tolerance is maintained.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881767      PMCID: PMC397074          DOI: 10.1073/pnas.82.2.536

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

2.  Bursting bacteria by release of gas pressure.

Authors:  D FRASER
Journal:  Nature       Date:  1951-01-06       Impact factor: 49.962

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  Cytotoxic T-cell precursors revealed in neonatally tolerant mice.

Authors:  B Stockinger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

6.  Nonspecific inhibitor released by T acceptor cells reduces the production of interleukin-2.

Authors:  M Malkovsky; G L Asherson; B Stockinger; M C Watkins
Journal:  Nature       Date:  1982-12-16       Impact factor: 49.962

Review 7.  Cellular mechanisms of immunologic tolerance.

Authors:  G J Nossal
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

8.  Functional clonal deletion in immunological tolerance to major histocompatibility complex antigens.

Authors:  G J Nossal; B L Pike
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

9.  Biological activity of recombinant human interleukin-2 produced in Escherichia coli.

Authors:  S A Rosenberg; E A Grimm; M McGrogan; M Doyle; E Kawasaki; K Koths; D F Mark
Journal:  Science       Date:  1984-03-30       Impact factor: 47.728

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  23 in total

1.  Enhancement of a delayed hypersensitivity reaction to a contact allergen, by the systemic administration of interleukin-2.

Authors:  Y Zaloom; L P Walsh; P McCulloch; G Gallagher
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

2.  Natural killer T cells are required for the development of a superantigen-driven T helper type 2 immune response in mice.

Authors:  Auro Nomizo; Edilberto Postol; Raquel de Alencar; Fabíola Cardillo; José Mengel
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

3.  Lymphokine-activated killer (LAK) cells modulate the effects of IL-2 on a T cell-mediated immune response.

Authors:  P McCulloch; G Gallagher; L P Walsh; Y Zaloom; J Xie
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

Review 4.  Immunotherapy I: Cyclosine gene transfer strategies.

Authors:  M P Colombo; G Forni
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

5.  Is human cell therapy research caught in a mousetrap?

Authors:  A John Barrett; J Joseph Melenhorst
Journal:  Mol Ther       Date:  2011-02       Impact factor: 11.454

Review 6.  The interleukins in acquired disease.

Authors:  M Malkovský; P M Sondel; W Strober; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

7.  Increased lymphokine activated killer (LAK) activity in the regional lymph nodes of mice following immunization with contact sensitizing agents.

Authors:  L Q Gao; G L Asherson; M Malkovsky
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

Review 8.  The purification of eukaryotic polypeptides synthesized in Escherichia coli.

Authors:  F A Marston
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

9.  Regulation of accessory cell function by retinoids in murine immune responses.

Authors:  D R Katz; M Drzymala; J A Turton; R M Hicks; R Hunt; L Palmer; M Malkovský
Journal:  Br J Exp Pathol       Date:  1987-06

10.  Autologous lymphoid cells exposed to recombinant interleukin-2 in vitro in the absence of antigen can induce the rejection of long-term tolerated skin allografts.

Authors:  B Loveland; R Hunt; M Malkovský
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.